Novartis Halts Multiple Clinical Trials Following Patient Deaths in Switzerland

Swiss pharmaceutical giant Novartis has suspended several experimental cell therapy studies after three participants died from a known complication, triggering regulatory reviews and safety assessments.

Post Share

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.

der-spiegelGerman18h ago

Pharmakonzern Novartis stoppt nach Todesfällen mehrere Studien

In der Schweiz sind drei Studienteilnehmer bei einer experimentellen Zelltherapie gestorben – offenbar an einer bekannten Komplikation. Novartis hat nun mehrere Studien ausgesetzt.

Read full article →

Novartis Halts Multiple Clinical Trials Following Patient Deaths in Switzerland

Sources

Pharmakonzern Novartis stoppt nach Todesfällen mehrere Studien

Related Stories

Irish Health Agency Fined €645,000 for Storing Records in Derelict Sites

New Urine Test Detects Over 90 Percent of Bladder Cancer Cases

Swimmer Hospitalized Following Suspected Shark Attack in Massachusetts

Wellington Clinics Suspends Kidney Transplants Amid Organ Harvesting Probe